Factor Bioscience Files Complaint Against Cellectis & Astrazeneca

ReutersSep 26, 2025 5:33 PM

View all comments（0）



Sept 26 (Reuters) - Cellectis SA ALCLS.PA:

FACTOR BIOSCIENCE: FILES COMPLAINT AGAINST CELLECTIS & ASTRAZENECA ALLEGING INFRINGEMENT OF FOUNDATIONAL GENE-EDITING PATENTS

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

Commenting Guidelines

Recommended Articles

Japan and South Korea Stocks Open Lower, Samsung Strike Storm and Higher-Than-Expected Inflation Disrupt Markets

TradingKey - On May 13, the Nikkei 225 Index opened 0.5% lower, while South Korea’s KOSPI Index opened down 1.7% before losses further widened to 3%.

Today’s Market Recap: US Inflation Hits 3-Year Peak as Market Braces for Trump’s China Visit and Fed Leadership Shift

April inflation hit a three-year peak of 3.8%, pressuring the Nasdaq and tech stocks. Markets are further braced by Kevin Warsh’s Fed Chair confirmation, the maintenance of Trump’s 10% global tariffs, and a high-profile U.S. business delegation preparing for a strategic state visit to China.

Renesas Electronics Rises Over 7%, SoftBank Rises Over 4%, Can Japanese Chip Stocks Replicate South Korean Stocks’ Soaring Rally?

TradingKey - On May 12, Japanese chip stocks strengthened significantly, with Renesas Electronics rising 7.14%, Sumitomo Metal Mining gaining 5.61%, and SoftBank Group advancing 4.25%. The Nikkei 225 Index climbed more than 700 points at one point during the day.

Cerebras Systems IPO 2026: Date, Price, Valuation, and Whether CBRS Is Worth Buying

TradingKey - Cerebras Systems (CBRS) IPO prices May 13–14 at $125–$135/share. $26–$27B valuation, 20x oversubscribed, $510M revenue, 47% net margin, OpenAI 750MW deal. Everything you need to know.

AMD Q1 Earnings: Data Center Revenue Surges 57% Driving Results Above Estimates, Shares Rise Over 16% After Hours

TradingKey - On May 5 (ET), Advanced Micro Devices (AMD) released its first-quarter fiscal 2026 financial results after the market close. The company reported revenue of $10.253 billion, up 38% year-over-year, exceeding market expectations of $9.89 billion. Non-GAAP earnings per share (EPS) were $1.

Featured Tools